|
Note
13 – Stock-based Compensation
The
Company’s Amended and Restated 2013 Equity Compensation Plan (the “Plan”) provides for the granting of incentive stock
options, nonqualified stock options, restricted stock units, performance units, and stock purchase rights. There were no significant
modifications to the Plan during the three months ended March 31, 2023 and 2022.
The
following table contains information about the Company’s stock plan at March 31, 2023:
Schedule
of Equtiy Compensation Plan by Arrangements
| |
|
Awards
Reserved for
Issuance |
|
|
Awards
Issued &
Exercised |
|
|
Awards
Available
for Grant |
|
| 2013 Equity Compensation Plan |
|
|
54,294 |
* |
|
|
39,359 |
** |
|
|
14,935 |
|
| * |
Increased
by 8,691 on January 1, 2023, representing 4% of the total number of shares of common stock outstanding on December 31, 2022. |
| ** |
Includes
both restricted stock grants and option grants |
The
Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of
operations as follows:
Schedule
of Recognized Stock Based Compensation
| |
|
Three Months Ended March 31, |
|
| |
|
2023 |
|
|
2022 |
|
| Research and Development |
|
$ |
553 |
|
|
$ |
550 |
|
| General and Administrative |
|
|
719 |
|
|
|
710 |
|
| Total |
|
$ |
1,272 |
|
|
$ |
1,260 |
|
As
of March 31, 2023, total compensation costs related to unvested awards not yet recognized was $8,690 and the weighted-average periods
over which the awards are expected to be recognized was 2.4 years.
Stock
Options
The
following table summarizes the activity for Company’ stock options for the three months ended March 31, 2023:
Schedule
of Stock Option Activity
| |
|
Stock
Options |
|
| Outstanding
at December 31, 2022 |
|
|
34,739 |
|
| Granted |
|
|
20 |
|
| Exercised |
|
|
- |
|
| Forfeited |
|
|
(81 |
) |
| Expired |
|
|
- |
|
| Outstanding
at March 31, 2023 |
|
|
34,678 |
|
|